ResMed Financial Diagnostics

RMD -- USA Stock  

USD 108.81  0.52  0.48%

ResMed diagnostics interface makes it easy to digest most current publicly released information about ResMed as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis ResMed price relationship with some important fundamental indicators such as market cap and management efficiency.

ResMed Note

About 64.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.64. ResMed last dividend was issued on 2018-05-09. This company had 2:1 split on 2010-08-31. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and traded on BATS Exchange. It employs 6000 people. To find out more about RESMED INC contact Michael Farrell at 858-836-5000 or learn more at http://www.resmed.com.

ResMed Alerts

About 64.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Sale by Hollingshead James of 600 shares of ResMed

ResMed Upcoming Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 27, 2017

ResMed Earning Estimates

EPSEstimate Date
Quarterly Estimate0.7April 25, 2017
ResMed normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

ResMed Thematic Classifications

Obamacare Repeal IdeaObamacare Repeal
Large healthcare related equities associated with Obamacare
Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French
Drugs IdeaDrugs
Drug manufacturing and delivery

Institutional Investors

Security TypeSharesValue
Baillie Gifford CoCommon Shares4.8 M500 M
American Capital Management IncCommon Shares643.2 K66.6 M
Welch Forbes LlcCommon Shares268.1 K27.8 M
Capital Investment Services Of America IncCommon Shares163.3 K16.9 M
Bank Of MontrealCommon Shares132.3 K13.7 M
Gateway Investment Advisers LlcCommon Shares116.6 K12.1 M
Copeland Capital Management LlcCommon Shares109.5 K11.3 M

Market Capitalization

The company currently falls under 'Large-Cap' category with total capitalization of 15.61 B.

Profitablity

The company has Net Profit Margin of 13.52 % which may imply that it executes well on its competitive polices and has a good control over its expenditures and variable costs. This is very large. In the same way, it shows Net Operating Margin of 28.58 % which entails that for every 100 dollars of revenue it generated 0.29 of operating income.

Management Efficiency

ResMed has Return on Asset of 9.58 % which means that on every $100 spent on asset it made $9.58 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.68 % implying that it generated $15.68 on every 100 dollars invested.

Stock Holders for ResMed

Information
Ratio
Value
At Risk
BMO EqBMO Eq Wght US HlthCare Hdgd to CAD ETF 0.0245 (1.09) 
SPDR SPSPDR SP Health Care Equipment ETF(0.07) (1.88) 
VPMSXVantagepoint MidSmall Company Index II 0.00  0.00 
VALICVALIC Company I Mid Cap Index(0.13) (1.13) 
UMPSXProFunds UltraMid Cap Svc(0.11) (1.46) 
UMPIXProFunds UltraMid Cap Inv(0.0082) (1.70) 
MotleyMotley Fool Small Mid Cap Growth Inv(0.12) (1.06) 
SPDR SPSPDR SP 400 US Mid Cap ETF 0.00  0.00 
SPDR SPSPDR SP 400 US Mid Cap ETF(0.08) (1.37) 
SPDR SPSPDR SP 400 US Mid Cap ETF(0.12) (1.22) 
SheltonShelton SP Midcap Index Direct(0.17) (1.12) 
iSharesiShares Russell 2500 ETF 0.00  0.00 
ObesityThe Obesity ETF(0.08) (1.96) 
Schwab USSchwab US Mid Cap ETF(0.18) (1.18) 
Rydex MidRydex Mid Cap 1 5x Strategy H(0.09) (1.28) 
GuggenheimGuggenheim SP 500 Eq Weight HC ETF(0.05) (1.04) 
PrincipalPrincipal MidCap SP 400 Index R1(0.1) (1.21) 
NuSharesNuShares ESG Mid Cap Growth ETF 0.00  0.00 
NorthernNorthern Mid Cap Index(0.1) (1.14) 
VanEckVanEck Vectors SPASX MidCap ETF 0.00  0.00 

Technical Drivers

ResMed holds Coefficient Of Variation of 945.47, Semi Deviation of 1.26 and Risk Adjusted Performance of 0.0561. Compared with Fundamental Indicators, Macroaxis technical analysis interface allows you to check existing technical drivers of ResMed as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found nineteen technical drivers for ResMed which can be compared to its competitors. Please check ResMed Information Ratio, Value At Risk as well as the relationship between Value At Risk and Expected Short fall to decide if ResMed is priced some-what accurately providing market reflects its current price of 108.81 per share. Given that ResMed has Jensen Alpha of 0.1573, we recommend you check out ResMed recent market performance to make sure the company can sustain itself at future point.

ResMed Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
  
Execute Study
 
The output start index for this execution was eleven with a total number of output elements of six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ResMed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ResMed. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

ResMed Insider Trading Activities

ResMed Technical and Predictive Indicators

ResMed Forecast Models

Recommendations

ResMed Analyst Recommendations
Target PriceAdvice# of Analysts
63.18Hold9Odds
ResMed current and past analyst recommendations published by number of research institutions as well as average analyst consensus
ResMed Analyst Advice  
Additionally take a look at Your Equity Center. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">